We are live on
!
Find out more
BCM
Beryl Capital Management Portfolio holdings
AUM
$110M
1-Year Est. Return
317.92%
This Fund
S&P 500
This Quarter
Est. Return
+24.63%
1 Year Est. Return
+317.92%
3 Year Est. Return
+5,124.04%
5 Year Est. Return
+10,319.28%
10 Year Est. Return
–
AUM
$52M
AUM Growth
-$612M
(-92%)
Cap. Flow
-$621M
Cap. Flow
% of AUM
-1,193.55%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
33
New
5
Increased
1
Reduced
–
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CleanSpark
CLSK
|
+$22.8M |
| 2 |
UnitedHealth
UNH
|
+$14.2M |
| 3 |
Bitdeer Technologies
BTDR
|
+$2.81M |
| 4 |
BGFV
Big 5 Sporting Goods
BGFV
|
+$1.25M |
| 5 |
ELME
Elme Communities
ELME
|
+$1.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BPMC
Blueprint Medicines
BPMC
|
+$137M |
| 2 |
SKX
Skechers
SKX
|
+$136M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$99.5M |
| 4 |
DNB
Dun & Bradstreet
DNB
|
+$66.3M |
| 5 |
VIGL
Vigil Neuroscience
VIGL
|
+$36.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 56.38% |
| 2 | Healthcare | 31.18% |
| 3 | Technology | 6.59% |
| 4 | Consumer Discretionary | 2.83% |
| 5 | Real Estate | 2.36% |
Similar funds
BCM
NMC
MCM
PXPO
FA
SCP
AC
BCM
Beryl Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Beryl Capital Management held 33 positions worth $52M, down 92% from $664M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Beryl Capital Management withdrew a net $621M in Q3 2025, closing 27 positions. Its most notable exit was Blueprint Medicines, an estimated $137M position sold in full.
By sector, the portfolio is most concentrated in Financials at 56% of assets, up from 12% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Beryl Capital Management opened a new position in CleanSpark worth $29.3M.
- Beryl Capital Management's largest Q3 2025 buy was CleanSpark: 2,023,507 shares worth $29.3M.
- Beryl Capital Management added most to Big 5 Sporting Goods in Q3 2025, an estimated $1.25M increase.
- Beryl Capital Management fully exited Blueprint Medicines in Q3 2025, selling an estimated $137M.
- Beryl Capital Management's ten largest holdings make up 100% of its $52M portfolio in Q3 2025.
- Beryl Capital Management opened 5 new positions and closed 27 in Q3 2025.
- Beryl Capital Management's portfolio value fell 92% quarter-over-quarter to $52M.
Based on Beryl Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.